These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17935961)
1. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Aerni MR; Aubry MC; Myers JL; Vassallo R Respir Med; 2008 Feb; 102(2):316-9. PubMed ID: 17935961 [TBL] [Abstract][Full Text] [Related]
2. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine. Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311 [TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. Choi SW; Bangaru BS; Wu CD; Finlay JL J Pediatr Hematol Oncol; 2003 Jun; 25(6):503-6. PubMed ID: 12794533 [TBL] [Abstract][Full Text] [Related]
4. Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine. Ottaviano F; Finlay JL J Pediatr Hematol Oncol; 2003 Jul; 25(7):575-7. PubMed ID: 12847329 [TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine. Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001 [TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review. Néel A; Artifoni M; Fontenoy AM; Tessoulin B; Lorillon G; Cohen-Aubart F; Haroche J; Genereau T; de Menthon M; Guillevin L; Maillard H; Kahn JE; Hermine O; Araujo C; Dromer C; Jullien D; Hamidou M; Donadieu J; Tazi A Br J Haematol; 2020 Jun; 189(5):869-878. PubMed ID: 32191819 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Langerhans cell histiocytosis with 2 chlorodeoxyadenosine. Dimopoulos MA; Theodorakis M; Kostis E; Papadimitris C; Moulopoulos LA; Anastasiou-Nana M Leuk Lymphoma; 1997 Mar; 25(1-2):187-9. PubMed ID: 9130627 [TBL] [Abstract][Full Text] [Related]
8. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine]. Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697 [TBL] [Abstract][Full Text] [Related]
9. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Pardanani A; Phyliky RL; Li CY; Tefferi A Mayo Clin Proc; 2003 Mar; 78(3):301-6. PubMed ID: 12630583 [TBL] [Abstract][Full Text] [Related]
10. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Stine KC; Saylors RL; Williams LL; Becton DL Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis. Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment with 2-chlorodeoxyadenosine of refractory pediatric Langerhans cell histiocytosis with initial involvement of the gastrointestinal tract. Mayumi A; Imamura T; Sakamoto K; Ota T; Osone S; Usami I; Hosoi H Int J Hematol; 2019 Dec; 110(6):756-762. PubMed ID: 31350665 [TBL] [Abstract][Full Text] [Related]
13. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Rodriguez-Galindo C; Kelly P; Jeng M; Presbury GG; Rieman M; Wang W Am J Hematol; 2002 Mar; 69(3):179-84. PubMed ID: 11891804 [TBL] [Abstract][Full Text] [Related]
14. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis]. Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874 [TBL] [Abstract][Full Text] [Related]
15. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. Lorillon G; Bergeron A; Detourmignies L; Jouneau S; Wallaert B; Frija J; Tazi A Am J Respir Crit Care Med; 2012 Nov; 186(9):930-2. PubMed ID: 23118088 [No Abstract] [Full Text] [Related]
17. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review]. Yao X; Ying H; Weihong Z; Qing S; Xintian L Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506 [TBL] [Abstract][Full Text] [Related]
18. [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma]. Szturz P; Adam Z; Rehák Z; Koukalová R; Kodet R; Nebeský T; Neubauer J; Moulis M; Smardová L; Mayer J Vnitr Lek; 2010 Nov; 56(11):1177-93. PubMed ID: 21250497 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients]. Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165 [TBL] [Abstract][Full Text] [Related]